Bristol-Myers Squibb Company
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
Last updated:
Abstract:
Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
Status:
Grant
Type:
Utility
Filling date:
23 Sep 2019
Issue date:
10 Aug 2021